Together we will beat cancer

Donate

New immunotherapy drugs hit the headlines – how do they work?

In the light of continued media attention, we explain the science behind two exciting new types of immunotherapy drug, called PD-1 and PD-L1 blockers.

Read More

ASCO 2013 – personalised medicine: potential and challenges

In our third instalment from the ASCO cancer conference, Debbie Coates writes about a major theme of modern cancer research…

Read More

ASCO 2013 – clinical trials for older cancer patients

In our second report from this year’s ASCO conference, Trevor Bott writes about a session he attended on the need…

Read More

ASCO 2013 – doctors encourage cancer patients to quit smoking

The world’s largest cancer conference, ASCO, is underway in Chicago. Among the many thousands of doctors and researchers, our nurses…

Read More

Podcast: Curry chemical on trial, death rates fall, ASCO conference highlights and more

This month, a new trial looks at the cancer-fighting properties of the curry chemical curcumin, while we take a look…

Read More

ASCO 2012 – best of the rest

In her third and final report from this year’s ASCO conference, Nell Barrie reflects on her personal highlights of the…

Read More

ASCO 2012 – a new treatment for HER2-positive breast cancer?

In this second report from the ASCO conference, Nell Barrie discusses an experimental “armed antibody” for the treatment of breast…

Read More

ASCO 2012: Is immunotherapy finally coming of age?

While the UK enjoyed the rather wet Jubilee celebrations this weekend, thousands of cancer experts gathered in Chicago for the…

Read More

ASCO 2011 – Jury still out on ovarian cancer screening

Thanks to research and improved treatments, survival from ovarian cancer has almost doubled over the last 30 years. Yet more…

Read More

Making research count for patients – the multiple myeloma story

This year at the ASCO conference in the US, several sessions reflected on the rapid progress that has been made…

Read More